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Abstract: Amber, the fossilized resin from the extinct family of pine tree, Sciadopityaceae, is 
used extensively in medicinal folklore. It is reported to have analgesic, anti-infective, 
antifungal, wound healing, anti-inflammatory, and anticancer properties. Amber, and 
specifically Baltic amber, has medicinal potential, yet a comprehensive analysis of the 
compounds in Baltic amber and their bioactive properties has yet to be done. The goal of this 
project is to separate the potentially bioactive small molecules in the amber and test them 
against different assays. This project is still in progress, but the completed research has 
produced a class of compounds, abietic acid derivatives, with medicinal potential. 
1. Introduction 
Amber is the fossilized resin of tree sap from 
the extinct family of pine trees 
Sciadopityaceae of the Eocene era 44 million 
years ago.
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 Amber is mentioned commonly in 
medicinal folklore for the treatment of many 
different ailments and said to have analgesic, 
anti-infective, anti-fungal, wound healing, 
anti-inflammatory, and anti-cancer properties.
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This project focuses on amber from the Baltic 
region, known as class Ia amber, because it is 
the only class of amber known to contain 
succinic acid and its different derivatives.
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The succinic acid derivatives in Baltic amber 
have been researched, yet a complete study of 
all of the compounds in Baltic amber has not 
been done. This project focuses on the non-
succinic acid containing compounds that can 
be found in Baltic amber and their medicinal 
properties. This project is still in progress, and 
specific results may not be published yet. This 
URS project is a snapshot of the larger Baltic 
Amber project in progress at the Ambrose lab, 
and does not include the work done on this 
project before or after the timeline of the URS 
project. In short, this is a small piece of a 
larger project. 
2. Materials and Methods 
Extractions: 
Before this URS project was started, four 
different extraction processes were optimized 
using 2 different solvent systems. The two 
solvents used for the extractions are 
dichloromethane (DCM) and ethanol (EtOH). 
EtOH was used for all 4 extraction methods, 
but DCM was only used for 3 of the extraction 
methods. 
The four extraction methods used were a 
conservative extraction, a soxhlet extraction, a 
sonication extraction, and a decoction 
extraction. The decoction extraction was only 
done with EtOH as the solvent. This gave 7 
different extracts for analysis. 
TLC optimization 
A TLC solvent system was optimized for TLC 
analysis of the compounds. The TLC plates 
were analyzed with UV light, and with a p-
anisaldehyde stain. The different solvent 
systems tested in the optimization are 
summarized in the following table. 
Summary of TLC Solvent Systems
Solvent 
System 
EtOAc/ 
hexanes 
MeOH/DCM EtOAc-
MeOH(10% 
MeOH)/hexanes 
Hexane/benzene/ 
MeOH 
Percentage 
of 1st 
listed 
solvent 
10% 0% 20% 2 parts/6 parts/1 
part 
  20% 10% 30% - 
  30% 20% 40% - 
  40% 30% 50% - 
  50% 40% 60% - 
  60% 50% - - 
  70% 60% - - 
  80% 70% - - 
  90% - - - 
 
 
 
 
GC-MS 
GC-MS analysis was done with an Agilent 
QTOF instrument. The optimization of the 
GC-MS conditions was completed by the 
graduate student working on this project. All 7 
of the extracts plus 8 standard compounds 
were run through the GC-MS. This instrument 
is connected with a database to aide in 
identifying the compounds from their 
corresponding peaks. The 7 extracts were run 
through the GC-MS once, and then 
concentrated and run through the GC-MS 
again. The 8 standard compounds tested were: 
 1-methylnapthalene 
 2,6-dimethylnapthalene 
 Acenaphthene 
 Fluorene 
 Phenanthrene 
 Retene 
 Anthracene 
 2-methylanthracene 
 9-methylanthracene 
 
3. Results 
It was hoped that use of a TLC-MS instrument 
could be integrated into the analysis of the 
different extracts, for this reason, the TLC 
conditions were optimized. When analysis of 
the extracts through TLC-MS was attempted, 
inconclusive, and useless results were obtained 
and will not be included as there is no 
discernable meaning to these results. 
Analysis through GC-MS provided much more 
conclusive results. Because this URS project is 
just a snapshot of the larger Baltic Amber 
project, the specifics of these results may not 
be published at this point. Analysis through 
GC-MS gave a comprehensive view into the 
compounds contained in Baltic amber. One 
class of compounds found in the extracts, 
abietic acid derivatives, is of particular 
interest. The mere presence of abietic acid 
derivatives is the only result of the GC-MS 
analysis that may be published as of right now. 
 
 
Table 1: This table outlines the 4 solvent systems that were tested through TLC,and the 
percentages of each component of the solvent system where the percentage listed is that of the first 
listed component. The EtOAc-MeOH/Hexanes solvent system was a 10% MeOH 90% EtOAc 
solvent that was varied with hexanes where the total percentages of each solvent in the system for 
the 20% solvent system would be (.2*.1)= 2% MeOH, (.2*.9)= 18% EtOAc, and 80% hexanes. 
Similarily, the hexane/benzene/MeOH solvent system was not varied, but rather combined in a 
2:6:1 ratio, respectively, or 22.2% hexane, 66.7% benzene, and 11.1% MeOH. 
 
4. Discussion 
No meaningful results were obtained through 
use of TLC-MS for analysis. This was likely 
due to the low concentrations of each 
compound in the extracts. Because there are a 
large number of compounds found in each 
extract, the concentrations of each individual 
compound in the extract are very low. This 
leads to the conclusion, that analysis by TLC-
MS is not helpful for this application. 
The presence of abietic acid derivatives in the 
Baltic amber extracts is promising. Several 
studies have been done on abietic acids as a 
class of compounds. Abietic acids are reported 
to have many different medicinal properties. 
According to some of these reports, certain 
abietic acids have proved to have anti-
inflammatory, potential therapeutic effects in 
the treatment of asthma, potential anti-obesity 
effects, wound-healing effects, antibacterial, 
and anticancer effects.
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 Abietic acids have a 
lot of therapeutic potential, and their presence 
in Baltic amber is promising for the 
therapeutic potential of Baltic amber. Future 
steps for this project include isolation of the 
abietic acids from the extracts and testing with 
assays for medicinal properties. 
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